Casi pharmaceuticals announces pricing of $32,500,000 public offering of common stock

Rockville, md. and beijing, march 24, 2021 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a u.s. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the pricing of an underwritten public offering of 15,853,658 shares of its common stock at a price to the public of $2.05 per share.
CASI Ratings Summary
CASI Quant Ranking